ArticleAME case reports2026
Symptomatic intrahepatic subcapsular hematoma-derived liver cyst following laparoscopic cholecystectomy: a case report.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intrahepatic subcapsular hematoma (ISH) is a rare complication following laparoscopic cholecystectomy (LC). Although most reported cases occur in the early postoperative period and resolve with conservative treatment, the management of chronic or refractory ISH remains unclear. We report a delayed, symptomatic cystic lesion that developed from postoperative ISH and was treated laparoscopically. Case Description: A 70-year-old man receiving aspirin for a previous myocardial infarction underwent LC for cholelithiasis and cholecystitis. Aspirin was resumed on postoperative day (POD) 2. On POD 4, decreased hemoglobin and elevated C-reactive protein levels prompted computed tomography, which revealed an ISH extending from the gallbladder bed to the right hepatic lobe. The patient was initially managed conservatively. On POD 105, a hepatic cystic lesion approximately 15 cm in diameter was detected, without laboratory evidence of inflammation. On POD 380, worsening abdominal pain and elevated inflammatory markers suggested secondary infection. Percutaneous drainage on POD 385 produced only temporary improvement, and the lesion recurred. Laparoscopic fenestration was therefore performed on POD 510. Indocyanine green fluorescence imaging clearly distinguished the non-fluorescent cyst wall from the surrounding hepatic parenchyma and facilitated safe resection. The postoperative course was uneventful, and no recurrence was observed during 1 year of follow-up. Conclusions: ISH following LC may evolve over several months into a chronic cystic lesion and subsequently become infected. Long-term follow-up should be considered for persistent or enlarging ISH. When conservative management and percutaneous drainage fail, laparoscopic fenestration with indocyanine green fluorescence imaging may provide a safe and definitive treatment option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.